Evidence map›Paper›PMID 33066327›Full record

ArticleInternational journal of environmental research and public health2020

Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia

Anas A Khan, Yazed AlRuthia, Bander Balkhi, Sultan M Alghadeer, Mohamad-Hani Temsah, Saqer M Althunayyan, Yousef M Alsofayan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Cost of illness studies in COVID-19: a scoping review.Cost effectiveness and resource allocation : C/E · 2024
    Article
  11. Article
  12. The Economic Burden of the COVID-19 Pandemic in State of Kuwait.ClinicoEconomics and outcomes research : CEOR · 2024
    Article
  13. Economic burden due to COVID-19 in a Colombian Caribbean state, 2020 and 2021.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Anas A KhanDepartment of Emergency Medicine, College of Medicine, King Saud University, Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh 11451, Saudi Arabia.
Yazed AlRuthiaDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia.
Bander BalkhiDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia.
Sultan M AlghadeerDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, P.O. Box 2454, Riyadh 11451, Saudi Arabia.
Mohamad-Hani TemsahCollege of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
Saqer M AlthunayyanDepartment of Accident and Trauma, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-7994-3412
Yousef M AlsofayanGlobal Center for Mass Gatherings Medicine, Ministry of Health, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-7028-7930
King Saud University · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Saud Medical City · SAMinistry of Health · SA

Funding

King Saud University Researchers Supporting Project number (RSP-2020/16)
6 · The paper itself

Abstract

objectivesAssess the survival of hospitalized coronavirus disease 2019 (COVID-19) patients across age groups, sex, use of mechanical ventilators (MVs), nationality, and intensive care unit (ICU) admission in the Kingdom of Saudi Arabia.

methodsData were retrieved from the Saudi Ministry of Health (MoH) between 1 March and 29 May 2020. Kaplan-Meier (KM) analyses and multiple Cox proportional-hazards regression were conducted to assess the survival of hospitalized COVID-19 patients from hospital admission to discharge (censored) or death. Micro-costing was used to estimate the direct medical costs associated with hospitalization per patient.

resultsThe number of included patients with complete status (discharge or death) was 1422. The overall 14-day survival was 0.699 (95%CI: 0.652-0.741). Older adults (>70 years) (HR = 5.00, 95%CI = 2.83-8.91), patients on MVs (5.39, 3.83-7.64), non-Saudi patients (1.37, 1.01-1.89), and ICU admission (2.09, 1.49-2.93) were associated with a high risk of mortality. The mean cost per patient (in SAR) for those admitted to the general Medical Ward (GMW) and ICU was 42,704.49 ± 29,811.25 and 79,418.30 ± 55,647.69, respectively.

conclusionThe high hospitalization costs for COVID-19 patients represents a significant public health challenge. Efficient allocation of healthcare resources cannot be emphasized enough.

Indexed as

AgedCoronavirus InfectionsCOVID-19FemaleHealth Care CostsHospitalizationHumansMalePandemicsPneumonia, ViralSaudi ArabiaSurvival AnalysisCOVID-19health care costshospitalizationmortalitySaudi Arabia

Identifiers

PMID33066327
PMCPMC7602112
OpenAlexW3091885850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.